Masatoshi Hasegawa Selected Research

Anthracyclines

10/2022

Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masatoshi Hasegawa Research Topics

Disease

32	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2009
22	Neoplasms (Cancer) 01/2022 - 09/2002
13	Neoplasm Metastasis (Metastasis) 01/2024 - 10/2004
10	Pancreatic Neoplasms (Pancreatic Cancer) 02/2019 - 11/2009
10	Lymphoma (Lymphomas) 10/2014 - 01/2002
7	Lower Urinary Tract Symptoms 01/2022 - 12/2014
5	Carcinoma (Carcinomatosis) 08/2006 - 01/2004
3	Hypoxia (Hypoxemia) 01/2022 - 11/2002
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2006 - 10/2004
2	Second Primary Neoplasms (Neoplasms, Second) 09/2022 - 09/2006
2	Overactive Urinary Bladder (Overactive Bladder) 01/2022 - 08/2017
2	Margins of Excision 06/2019 - 10/2014
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2016 - 03/2006
2	Lung Neoplasms (Lung Cancer) 05/2015 - 05/2008
2	Squamous Cell Carcinoma of Head and Neck 04/2015 - 07/2013
2	Brain Neoplasms (Brain Tumor) 01/2014 - 01/2006
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2012 - 01/2006
2	Glioblastoma (Glioblastoma Multiforme) 05/2011 - 02/2009
2	Fibrosis (Cirrhosis) 01/2010 - 03/2006
2	Adenocarcinoma of Lung 05/2008 - 09/2005
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 11/2007 - 09/2003
1	Extranodal NK-T-Cell Lymphoma 10/2022
1	Erectile Dysfunction 02/2022
1	Hypertension (High Blood Pressure) 02/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Insulin Resistance 01/2021
1	Hypercholesterolemia 01/2021
1	Obesity 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Necrosis 07/2020
1	Central Nervous System Diseases (CNS Diseases) 01/2020
1	Nausea 12/2019
1	Vomiting 12/2019
1	Rupture 03/2019
1	Arteriovenous Malformations (Arteriovenous Malformation) 03/2019
1	Xeroderma Pigmentosum (Kaposi's Disease) 01/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2019
1	Skin Diseases (Skin Disease) 01/2019
1	Breast Neoplasms (Breast Cancer) 04/2017
1	Uterine Neoplasms (Uterine Cancer) 01/2016
1	Genomic Instability 01/2016

Drug/Important Bio-Agent (IBA)

5	Iodine-125IBA 01/2019 - 01/2009
4	Prostate-Specific Antigen (Semenogelase)IBA 01/2020 - 10/2011
4	Gemcitabine FDA Link 02/2013 - 11/2009
3	AndrogensIBA 02/2022 - 10/2014
3	Fluorouracil (Carac)FDA LinkGeneric 11/2020 - 11/2009
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2020 - 05/2018
3	Adrenergic Receptors (Adrenergic Receptor)IBA 10/2019 - 12/2014
3	DNA (Deoxyribonucleic Acid)IBA 05/2017 - 05/2011
2	Testosterone (Sustanon)FDA Link 02/2022 - 01/2020
2	GadoliniumIBA 01/2022 - 07/2020
2	Tamsulosin (Flomax)FDA LinkGeneric 01/2022 - 09/2020
2	AcidsIBA 01/2022 - 09/2020
2	silodosin FDA Link 11/2021 - 12/2014
2	naftopidilIBA 11/2021 - 12/2014
2	Antineoplastic Agents (Antineoplastics)IBA 11/2020 - 05/2008
2	Deoxyglucose (2 Deoxy D glucose)IBA 04/2015 - 04/2012
1	AnthracyclinesIBA 10/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	protoporphyrin IXIBA 01/2022
1	mirabegronIBA 01/2022
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Uric Acid (Urate)IBA 01/2021
1	AmberIBA 09/2020
1	Celecoxib (Celebrex)FDA Link 09/2020
1	Bevacizumab (Avastin)FDA Link 07/2020
1	Small Cytoplasmic RNAIBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2019
1	PlasticsIBA 02/2019
1	purineIBA 01/2019
1	Pyrimidine DimersIBA 01/2019
1	8,5'-cyclo-2'-deoxyadenosineIBA 01/2019
1	2-(morpholin-4-yl)benzo(h)chromen-4-oneIBA 05/2017
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2017
1	CationsIBA 04/2017
1	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 04/2017
1	Organic Anion TransportersIBA 04/2017
1	Proteins (Proteins, Gene)FDA Link 04/2017
1	Peptides (Polypeptides)IBA 04/2017
1	AnionsIBA 04/2017
1	BoronIBA 03/2016
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 01/2016
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2016

Therapy/Procedure

41	Radiotherapy 01/2024 - 01/2002
28	Brachytherapy 01/2023 - 01/2004
10	Therapeutics 10/2022 - 01/2002
9	Drug Therapy (Chemotherapy) 06/2016 - 01/2002
6	Neoadjuvant Therapy 02/2019 - 11/2011
4	Prostatectomy (Retropubic Prostatectomy) 01/2023 - 10/2014
4	Chemoradiotherapy 04/2015 - 07/2005
3	Particle Accelerators 01/2024 - 01/2022
2	Adjuvant Chemotherapy 09/2018 - 11/2009
2	Pancreatectomy 09/2018 - 06/2016
2	Catheters 06/2016 - 11/2011
2	Salvage Therapy 10/2014 - 09/2003
1	Stents 02/2019
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2018
1	Vascular Access Devices (Arterial Line) 06/2016
1	Boron Neutron Capture Therapy 03/2016